Molecular Mechanisms of Donor Dominance in Androgenetic Alopecia

April 2018 in “ Journal of Investigative Dermatology ”

Y. Doucet, J. C. Chen, Hasan E. Abaci, Colin A.B. Jahoda, Angela M. Christiano

androgenetic alopecia AGA RNA seq differential gene expression cranial-caudal axis biosignatures genetic factors epigenetic factors developmental factors hair follicle scalp dermis parietal scalp occipital scalp hair loss gene expression skin development hair pattern scalp

TLDR Hair pattern in androgenetic alopecia overlaps with scalp and bone demarcations, with distinct gene profiles affecting susceptibility.

The study investigates the molecular mechanisms of donor dominance in androgenetic alopecia (AGA) and found that the hair pattern in AGA overlaps with the demarcations of scalp dermis/underlying bones. Computational analyses of RNA seq from parietal and occipital scalp of matching control and AGA affected volunteers revealed a differential gene expression profile along the cranial-caudal axis defining two distinct biosignatures that reflect the developmental origins of the skin and the susceptibility to develop AGA. The study provides novel insights into the genetic, epigenetic, and developmental factors required for temporal specification of the skin and the interdependence of hair follicle, skull and craniofacial development.

View this study on jidonline.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

in Research/Science 136 upvotes 7 months ago

The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 1 month ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.

community Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US

in Research/Science 120 upvotes 1 year ago

Kintor Pharma announced successful Phase II trial results for KX-826 in treating hair loss, showing it's comparable to finasteride and can be used with it. Some participants saw a 10 hair/cm^2 increase, which is considered a good outcome at the low dose used.

community When someone posts a scalp tension theory

in Satire 267 upvotes 3 years ago

Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.

community Why balding gets worse in every generation?

in Chat 81 upvotes 5 months ago

Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

community Quit vaping/smoking = 80% less loss

in Research/Science 235 upvotes 7 months ago

Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

Related Research

1 / 1 results

research Androgenetic Alopecia: An Autosomal Dominant Disorder

80 citations, January 1995 in “The American Journal of Medicine”

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.